Alterations Induced in Heme Pathway Enzymes and Monooxygenases by Gold

In this study, the effects of the gold compound, gold sodium thiomalate, on the heme biosynthetic pathway, on cytochrome P-450-dependent monooxygenases, and on heme catabolism were examined. The addition of the gold compound, in vitro , resulted in the inhibition of hepatic δ-aminolevulinic acid de...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular pharmacology 1978-11, Vol.14 (6), p.1176-1188
Hauptverfasser: Eiseman, J L, Alvares, A P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1188
container_issue 6
container_start_page 1176
container_title Molecular pharmacology
container_volume 14
creator Eiseman, J L
Alvares, A P
description In this study, the effects of the gold compound, gold sodium thiomalate, on the heme biosynthetic pathway, on cytochrome P-450-dependent monooxygenases, and on heme catabolism were examined. The addition of the gold compound, in vitro , resulted in the inhibition of hepatic δ-aminolevulinic acid dehydratase, NADPH-cytochrome c reductase, and ethylmorphine N-demethylase activities. There was also a slight decrease in cytochrome P-450 content. Gold was a noncompetitive inhibitor of both δ-aminolevulinic acid dehydratase and ethylmorphine N-demethylase activities. Gold sodium thiomalate, administered acutely, altered heme biosynthetic pathway enzymes in erythrocytes, liver, and kidney. Erythrocyte δ-aminolevulinic acid dehydratase activity was decreased with a concomitant increase in protoporphyrin content. In the liver δ-aminolevulinic acid dehydratase and ferrochelatase activities were significantly inhibited and the microsomal heme content was significantly decreased. In the kidney, the major site of gold deposition, the activities of δ-aminolevulinic acid synthase, δ-aminolevulinic acid dehydratase, and ferrochelatase were markedly inhibited and total porphyrin content was markedly decreased. After acute gold treatment, monooxygenase activities in liver and kidney were decreased. Cytochrome P-450 content of both tissues decreased significantly and ethylmorphine N-demethylase and benzo(a)pyrene hydroxylase activities were both inhibited. NADPH-cytochrome c reductase activity, however, was not altered. In contrast to its inhibitory effects on the heme biosynthetic pathway and cytochrome P-450-dependent monooxygenases, gold caused a 1.5- and 8-fold induction in the liver and kidney, respectively, of microsomal heme oxygenase activity, the rate-limiting enzyme in the catabolism of heme. There was no change in any of the parameters in the liver or erythrocytes after chronic treatment with gold. In the kidney, δ-aminolevulinic acid dehydratase activity and total porphyrins were significantly decreased. However, as in the liver, cytochrome P-450 content was not significantly altered. These results indicate that an adaptive response develops during chronic gold treatment which prevents the depression of heme biosynthesis and the formation of cytochrome P-450.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_74316070</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>74316070</sourcerecordid><originalsourceid>FETCH-LOGICAL-h151t-1cc8cef4a98b485514efbc11d2a4537b2c37ed5a37adb988fbf2bc3e9597d8473</originalsourceid><addsrcrecordid>eNpFj0tLw0AURgfxVav_wEVW7gJzMzOdybKUvqCiCwV3YR43TSSZqZmEGn-9hQquPjgcDnwXZAIig5QCwCWZUJrNUpWLj1tyF-MnpcCFojfkGigHziZkNW967HRfBx-TrXeDRZfUPtlgi8mr7qujHpOl_xlbjIn2LnkOPoTvcY9exxMyY7IOjbsnV6VuIj787ZS8r5Zvi026e1lvF_NdWoGAPgVrlcWS61wZroQAjqWxAC7TXDBpMsskOqGZ1M7kSpWmzIxlmItcOsUlm5Knc_fQha8BY1-0dbTYNNpjGGIhOYMZlfQkPv6Jg2nRFYeubnU3Fuff_52q3lfHusPiUOmu1TY0YX-yeDErAOSM_QKrDWJw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>74316070</pqid></control><display><type>article</type><title>Alterations Induced in Heme Pathway Enzymes and Monooxygenases by Gold</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Eiseman, J L ; Alvares, A P</creator><creatorcontrib>Eiseman, J L ; Alvares, A P</creatorcontrib><description>In this study, the effects of the gold compound, gold sodium thiomalate, on the heme biosynthetic pathway, on cytochrome P-450-dependent monooxygenases, and on heme catabolism were examined. The addition of the gold compound, in vitro , resulted in the inhibition of hepatic δ-aminolevulinic acid dehydratase, NADPH-cytochrome c reductase, and ethylmorphine N-demethylase activities. There was also a slight decrease in cytochrome P-450 content. Gold was a noncompetitive inhibitor of both δ-aminolevulinic acid dehydratase and ethylmorphine N-demethylase activities. Gold sodium thiomalate, administered acutely, altered heme biosynthetic pathway enzymes in erythrocytes, liver, and kidney. Erythrocyte δ-aminolevulinic acid dehydratase activity was decreased with a concomitant increase in protoporphyrin content. In the liver δ-aminolevulinic acid dehydratase and ferrochelatase activities were significantly inhibited and the microsomal heme content was significantly decreased. In the kidney, the major site of gold deposition, the activities of δ-aminolevulinic acid synthase, δ-aminolevulinic acid dehydratase, and ferrochelatase were markedly inhibited and total porphyrin content was markedly decreased. After acute gold treatment, monooxygenase activities in liver and kidney were decreased. Cytochrome P-450 content of both tissues decreased significantly and ethylmorphine N-demethylase and benzo(a)pyrene hydroxylase activities were both inhibited. NADPH-cytochrome c reductase activity, however, was not altered. In contrast to its inhibitory effects on the heme biosynthetic pathway and cytochrome P-450-dependent monooxygenases, gold caused a 1.5- and 8-fold induction in the liver and kidney, respectively, of microsomal heme oxygenase activity, the rate-limiting enzyme in the catabolism of heme. There was no change in any of the parameters in the liver or erythrocytes after chronic treatment with gold. In the kidney, δ-aminolevulinic acid dehydratase activity and total porphyrins were significantly decreased. However, as in the liver, cytochrome P-450 content was not significantly altered. These results indicate that an adaptive response develops during chronic gold treatment which prevents the depression of heme biosynthesis and the formation of cytochrome P-450.</description><identifier>ISSN: 0026-895X</identifier><identifier>EISSN: 1521-0111</identifier><identifier>PMID: 104143</identifier><language>eng</language><publisher>United States: American Society for Pharmacology and Experimental Therapeutics</publisher><subject>Animals ; Erythrocytes - enzymology ; Gold - pharmacology ; Gold Sodium Thiomalate - pharmacology ; Heme - metabolism ; In Vitro Techniques ; Kidney - enzymology ; Kinetics ; Liver - enzymology ; Male ; Microsomes - enzymology ; Mixed Function Oxygenases - metabolism ; Oxidoreductases - metabolism ; Porphobilinogen Synthase - metabolism ; Rats ; Time Factors</subject><ispartof>Molecular pharmacology, 1978-11, Vol.14 (6), p.1176-1188</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/104143$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Eiseman, J L</creatorcontrib><creatorcontrib>Alvares, A P</creatorcontrib><title>Alterations Induced in Heme Pathway Enzymes and Monooxygenases by Gold</title><title>Molecular pharmacology</title><addtitle>Mol Pharmacol</addtitle><description>In this study, the effects of the gold compound, gold sodium thiomalate, on the heme biosynthetic pathway, on cytochrome P-450-dependent monooxygenases, and on heme catabolism were examined. The addition of the gold compound, in vitro , resulted in the inhibition of hepatic δ-aminolevulinic acid dehydratase, NADPH-cytochrome c reductase, and ethylmorphine N-demethylase activities. There was also a slight decrease in cytochrome P-450 content. Gold was a noncompetitive inhibitor of both δ-aminolevulinic acid dehydratase and ethylmorphine N-demethylase activities. Gold sodium thiomalate, administered acutely, altered heme biosynthetic pathway enzymes in erythrocytes, liver, and kidney. Erythrocyte δ-aminolevulinic acid dehydratase activity was decreased with a concomitant increase in protoporphyrin content. In the liver δ-aminolevulinic acid dehydratase and ferrochelatase activities were significantly inhibited and the microsomal heme content was significantly decreased. In the kidney, the major site of gold deposition, the activities of δ-aminolevulinic acid synthase, δ-aminolevulinic acid dehydratase, and ferrochelatase were markedly inhibited and total porphyrin content was markedly decreased. After acute gold treatment, monooxygenase activities in liver and kidney were decreased. Cytochrome P-450 content of both tissues decreased significantly and ethylmorphine N-demethylase and benzo(a)pyrene hydroxylase activities were both inhibited. NADPH-cytochrome c reductase activity, however, was not altered. In contrast to its inhibitory effects on the heme biosynthetic pathway and cytochrome P-450-dependent monooxygenases, gold caused a 1.5- and 8-fold induction in the liver and kidney, respectively, of microsomal heme oxygenase activity, the rate-limiting enzyme in the catabolism of heme. There was no change in any of the parameters in the liver or erythrocytes after chronic treatment with gold. In the kidney, δ-aminolevulinic acid dehydratase activity and total porphyrins were significantly decreased. However, as in the liver, cytochrome P-450 content was not significantly altered. These results indicate that an adaptive response develops during chronic gold treatment which prevents the depression of heme biosynthesis and the formation of cytochrome P-450.</description><subject>Animals</subject><subject>Erythrocytes - enzymology</subject><subject>Gold - pharmacology</subject><subject>Gold Sodium Thiomalate - pharmacology</subject><subject>Heme - metabolism</subject><subject>In Vitro Techniques</subject><subject>Kidney - enzymology</subject><subject>Kinetics</subject><subject>Liver - enzymology</subject><subject>Male</subject><subject>Microsomes - enzymology</subject><subject>Mixed Function Oxygenases - metabolism</subject><subject>Oxidoreductases - metabolism</subject><subject>Porphobilinogen Synthase - metabolism</subject><subject>Rats</subject><subject>Time Factors</subject><issn>0026-895X</issn><issn>1521-0111</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1978</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFj0tLw0AURgfxVav_wEVW7gJzMzOdybKUvqCiCwV3YR43TSSZqZmEGn-9hQquPjgcDnwXZAIig5QCwCWZUJrNUpWLj1tyF-MnpcCFojfkGigHziZkNW967HRfBx-TrXeDRZfUPtlgi8mr7qujHpOl_xlbjIn2LnkOPoTvcY9exxMyY7IOjbsnV6VuIj787ZS8r5Zvi026e1lvF_NdWoGAPgVrlcWS61wZroQAjqWxAC7TXDBpMsskOqGZ1M7kSpWmzIxlmItcOsUlm5Knc_fQha8BY1-0dbTYNNpjGGIhOYMZlfQkPv6Jg2nRFYeubnU3Fuff_52q3lfHusPiUOmu1TY0YX-yeDErAOSM_QKrDWJw</recordid><startdate>197811</startdate><enddate>197811</enddate><creator>Eiseman, J L</creator><creator>Alvares, A P</creator><general>American Society for Pharmacology and Experimental Therapeutics</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>197811</creationdate><title>Alterations Induced in Heme Pathway Enzymes and Monooxygenases by Gold</title><author>Eiseman, J L ; Alvares, A P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h151t-1cc8cef4a98b485514efbc11d2a4537b2c37ed5a37adb988fbf2bc3e9597d8473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1978</creationdate><topic>Animals</topic><topic>Erythrocytes - enzymology</topic><topic>Gold - pharmacology</topic><topic>Gold Sodium Thiomalate - pharmacology</topic><topic>Heme - metabolism</topic><topic>In Vitro Techniques</topic><topic>Kidney - enzymology</topic><topic>Kinetics</topic><topic>Liver - enzymology</topic><topic>Male</topic><topic>Microsomes - enzymology</topic><topic>Mixed Function Oxygenases - metabolism</topic><topic>Oxidoreductases - metabolism</topic><topic>Porphobilinogen Synthase - metabolism</topic><topic>Rats</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Eiseman, J L</creatorcontrib><creatorcontrib>Alvares, A P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Eiseman, J L</au><au>Alvares, A P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Alterations Induced in Heme Pathway Enzymes and Monooxygenases by Gold</atitle><jtitle>Molecular pharmacology</jtitle><addtitle>Mol Pharmacol</addtitle><date>1978-11</date><risdate>1978</risdate><volume>14</volume><issue>6</issue><spage>1176</spage><epage>1188</epage><pages>1176-1188</pages><issn>0026-895X</issn><eissn>1521-0111</eissn><abstract>In this study, the effects of the gold compound, gold sodium thiomalate, on the heme biosynthetic pathway, on cytochrome P-450-dependent monooxygenases, and on heme catabolism were examined. The addition of the gold compound, in vitro , resulted in the inhibition of hepatic δ-aminolevulinic acid dehydratase, NADPH-cytochrome c reductase, and ethylmorphine N-demethylase activities. There was also a slight decrease in cytochrome P-450 content. Gold was a noncompetitive inhibitor of both δ-aminolevulinic acid dehydratase and ethylmorphine N-demethylase activities. Gold sodium thiomalate, administered acutely, altered heme biosynthetic pathway enzymes in erythrocytes, liver, and kidney. Erythrocyte δ-aminolevulinic acid dehydratase activity was decreased with a concomitant increase in protoporphyrin content. In the liver δ-aminolevulinic acid dehydratase and ferrochelatase activities were significantly inhibited and the microsomal heme content was significantly decreased. In the kidney, the major site of gold deposition, the activities of δ-aminolevulinic acid synthase, δ-aminolevulinic acid dehydratase, and ferrochelatase were markedly inhibited and total porphyrin content was markedly decreased. After acute gold treatment, monooxygenase activities in liver and kidney were decreased. Cytochrome P-450 content of both tissues decreased significantly and ethylmorphine N-demethylase and benzo(a)pyrene hydroxylase activities were both inhibited. NADPH-cytochrome c reductase activity, however, was not altered. In contrast to its inhibitory effects on the heme biosynthetic pathway and cytochrome P-450-dependent monooxygenases, gold caused a 1.5- and 8-fold induction in the liver and kidney, respectively, of microsomal heme oxygenase activity, the rate-limiting enzyme in the catabolism of heme. There was no change in any of the parameters in the liver or erythrocytes after chronic treatment with gold. In the kidney, δ-aminolevulinic acid dehydratase activity and total porphyrins were significantly decreased. However, as in the liver, cytochrome P-450 content was not significantly altered. These results indicate that an adaptive response develops during chronic gold treatment which prevents the depression of heme biosynthesis and the formation of cytochrome P-450.</abstract><cop>United States</cop><pub>American Society for Pharmacology and Experimental Therapeutics</pub><pmid>104143</pmid><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0026-895X
ispartof Molecular pharmacology, 1978-11, Vol.14 (6), p.1176-1188
issn 0026-895X
1521-0111
language eng
recordid cdi_proquest_miscellaneous_74316070
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Animals
Erythrocytes - enzymology
Gold - pharmacology
Gold Sodium Thiomalate - pharmacology
Heme - metabolism
In Vitro Techniques
Kidney - enzymology
Kinetics
Liver - enzymology
Male
Microsomes - enzymology
Mixed Function Oxygenases - metabolism
Oxidoreductases - metabolism
Porphobilinogen Synthase - metabolism
Rats
Time Factors
title Alterations Induced in Heme Pathway Enzymes and Monooxygenases by Gold
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T17%3A50%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Alterations%20Induced%20in%20Heme%20Pathway%20Enzymes%20and%20Monooxygenases%20by%20Gold&rft.jtitle=Molecular%20pharmacology&rft.au=Eiseman,%20J%20L&rft.date=1978-11&rft.volume=14&rft.issue=6&rft.spage=1176&rft.epage=1188&rft.pages=1176-1188&rft.issn=0026-895X&rft.eissn=1521-0111&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E74316070%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=74316070&rft_id=info:pmid/104143&rfr_iscdi=true